Maron E - Search Results

1

Personality traits and escitalopram treatment outcome in major depression.

Aluoja A, Tõru I, Raag M, Eller T, Võhma Ü, Maron E. Aluoja A, et al. Among authors: maron e. Nord J Psychiatry. 2018 Jul;72(5):354-360. doi: 10.1080/08039488.2018.1465590. Epub 2018 Apr 24. Nord J Psychiatry. 2018. PMID: 29688152

2

Citalopram challenge in social anxiety disorder.

Shlik J, Maron E, Tru I, Aluoja A, Vasar V. Shlik J, et al. Among authors: maron e. Int J Neuropsychopharmacol. 2004 Jun;7(2):177-82. doi: 10.1017/S146114570300405X. Epub 2004 Jan 23. Int J Neuropsychopharmacol. 2004. PMID: 14741063 Free article. Clinical Trial.

3

The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.

Maron E, Tõru I, Vasar V, Shlik J. Maron E, et al. J Psychopharmacol. 2004 Jun;18(2):194-9. doi: 10.1177/0269881104042619. J Psychopharmacol. 2004. PMID: 15260907 Clinical Trial.

4

Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers.

Maron E, Tasa G, Tõru I, Lang A, Vasar V, Shlik J. Maron E, et al. World J Biol Psychiatry. 2004 Jul;5(3):149-54. doi: 10.1080/15622970410029927. World J Biol Psychiatry. 2004. PMID: 15346539

5

Associations between serotonin-related gene polymorphisms and panic disorder.

Maron E, Lang A, Tasa G, Liivlaid L, Tõru I, Must A, Vasar V, Shlik J. Maron E, et al. Int J Neuropsychopharmacol. 2005 Jun;8(2):261-6. doi: 10.1017/S1461145704004985. Epub 2005 Jan 26. Int J Neuropsychopharmacol. 2005. PMID: 15670397 Free article.

6

Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.

Tõru I, Shlik J, Maron E, Vasar V, Nutt DJ. Tõru I, et al. Among authors: maron e. Psychopharmacology (Berl). 2006 May;186(1):107-12. doi: 10.1007/s00213-006-0351-1. Epub 2006 Mar 16. Psychopharmacology (Berl). 2006. PMID: 16541242 Clinical Trial.

7

Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder.

Maron E, Tõru I, Must A, Tasa G, Toover E, Vasar V, Lang A, Shlik J. Maron E, et al. Neurosci Lett. 2007 Jan 16;411(3):180-4. doi: 10.1016/j.neulet.2006.09.060. Epub 2006 Nov 22. Neurosci Lett. 2007. PMID: 17123728

8

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

Eller T, Vasar V, Shlik J, Maron E. Eller T, et al. Among authors: maron e. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):445-50. doi: 10.1016/j.pnpbp.2007.09.015. Epub 2007 Sep 26. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 17976882 Clinical Trial.

9

Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder.

Eller T, Vasar V, Shlik J, Maron E. Eller T, et al. Among authors: maron e. J Psychopharmacol. 2009 Sep;23(7):854-8. doi: 10.1177/0269881108091077. Epub 2008 Jun 18. J Psychopharmacol. 2009. PMID: 18562403

10

CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.

Maron E, Tõru I, Mäemets K, Sepp S, Vasar V, Shlik J, Zharkovsky A. Maron E, et al. J Psychopharmacol. 2009 Jun;23(4):460-4. doi: 10.1177/0269881108089600. Epub 2008 Jun 18. J Psychopharmacol. 2009. PMID: 18562429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters